Abstract |
To investigate whether [(99m)Tc]-hexamethyl propyleneamine oxime ([(99m)Tc]-HMPAO) is applicable for evaluating glutathione (GSH) localization in tumor, the difference of distribution between [(99m)Tc]-d,l- and meso-HMPAO was studied using a mouse tumor model. Biodistribution of [(99m)Tc]-d,l- or meso-HMPAO was studied in GSH-depleted and control Ehrlich tumor-bearing mice. GSH levels in tumors in GSH-depleted and control mice were measured in another set of mice. The uptake of [(99m)Tc]-d,l-HMPAO in tumor was significantly decreased by the diethyl maleate (DEM) treatment. On the other hand, the DEM treatment increased the accumulation of [(99m)Tc]-meso-HMPAO in tumor. Meanwhile, the content of GSH was lowest in tumor among the tissues tested and decreased in a manner similar to other tissues on preloading of DEM. [(99m)Tc]-d,l-HMPAO may be useful for estimating the GSH status in a certain tumor and thereby contribute to the diagnosis of anticancer therapy.
|
Authors | N Shimura, A Musya, T Hashimoto, S Kojima, A Kubodera, T Sasaki |
Journal | Nuclear medicine and biology
(Nucl Med Biol)
Vol. 27
Issue 6
Pg. 577-80
(Aug 2000)
ISSN: 0969-8051 [Print] United States |
PMID | 11056372
(Publication Type: Journal Article)
|
Chemical References |
- Maleates
- Technetium Tc 99m Exametazime
- diethyl maleate
- Glutathione
|
Topics |
- Animals
- Brain
(diagnostic imaging, metabolism)
- Carcinoma, Ehrlich Tumor
(diagnostic imaging, metabolism)
- Glutathione
(metabolism)
- Kidney
(diagnostic imaging, metabolism)
- Liver
(diagnostic imaging, metabolism)
- Lung
(diagnostic imaging, metabolism)
- Male
- Maleates
(pharmacology)
- Mice
- Mice, Inbred Strains
- Neoplasm Transplantation
- Organ Specificity
(drug effects)
- Radionuclide Imaging
- Spleen
(diagnostic imaging, metabolism)
- Stereoisomerism
- Technetium Tc 99m Exametazime
(metabolism, pharmacokinetics)
- Tissue Distribution
|